TrialAmerican journal of respiratory and critical care medicine2015

A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.

Eric W F W Alton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.